Western blot showed that exogenous rHDGF (10 ng/mL) treatment significantly reduced the protein level of E-cadherin, an epithelial marker, while it elevated the protein levels of mesenchymal markers, including vimentin and α-SMA in melanoma cells (Fig. 5A). Here, CDH1 is linked to melanoma.